TTRX

Quote

Short

News

Articles

Message Board

Turn Therapeutics Inc. (NASDAQ : TTRX ) News

Turn Therapeutics Inc. (NASDAQ: TTRX) News Releases

TTRX News Releases

June 01, 2026 08:30:00 am

Business Wire

Turn Therapeutics Reports Interim Analysis Findings and Adaptive Optimization Strategy from Phase 2 GX-03 Trial in Moderate-to-Severe Atopic Dermatitis

May 27, 2026 08:05:00 am

Business Wire

Turn Therapeutics Announces Peer-Reviewed Publication in Journal of Dermatological Treatment Highlighting GX-03 Activity in IL-36 Associated Inflammatory Model

May 19, 2026 08:01:00 am

Business Wire

Turn Therapeutics to Present at Jefferies Global Healthcare Conference 2026

May 18, 2026 08:05:00 am

Business Wire

Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead

May 11, 2026 04:47:45 pm

SeekingAlpha

Turn Therapeutics Inc. GAAP EPS of -$0.03 misses by $0.01

May 11, 2026 04:05:00 pm

Business Wire

Turn Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates

March 31, 2026 04:39:41 pm

SeekingAlpha

Turn Therapeutics Inc. GAAP EPS of -$0.12 beats by $0.01

March 31, 2026 04:05:00 pm

Business Wire

Turn Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates

March 24, 2026 08:10:51 am

SeekingAlpha

Turn Therapeutics secures up to $25M in financing from Avenue Capital Group

March 24, 2026 08:00:00 am

Business Wire

Turn Therapeutics Secures Up to $25 Million in Financing From Avenue Capital Group

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account